Paper Review Records
All Paper Review Records
1 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
309
days
Anti–Receptor Activator of Nuclear Factor-κB Ligand Improves Muscle Dysfunction and Strengthens Bone in Laminin-α2–Deficient dy2J/dy2J Dystrophic Mice
Authors
Zineb Bouredji; Anthony Facchin; Dounia Hamoudi; Hideo Yagita; Norbert Laroche; Marthe Rousseau; Anteneh Argaw; Jérôme FrenetteShow moreShow less
Affiliations
1. Centre Hospitalier Universitaire de Québec–Université Laval Research Center, Axe Neurosciences, Université Laval, Quebec City, Quebec, Canada; 2. Department of Immunology, School of Medicine, Juntendo University, Tokyo, Japan; 3. Jean Monnet Université Saint-Étienne, INSERM, Mines Saint Étienne, Santé Ingénierie Biologie St-Étienne U1059, Saint-Étienne, France; 4. Unité Mixte de Recherche 5510 Matériaux Ingienrie et Science, Centre National de Recherche Scientifique/Lyon University/Institut National de Science Appliquée–Lyon, Lyon, France; 5. School of Rehabilitation Sciences, Faculty of Medicine, Université Laval, Quebec City, Quebec, CanadaShow moreShow less
FAQ
How long does AMERICAN JOURNAL OF PATHOLOGY take to review a manuscript?
As of 2026-11-19, CrushSCI has only 1 complete review record for AMERICAN JOURNAL OF PATHOLOGY: Anti–Receptor Activator of Nuclear Factor-κB Ligand Improves Muscle Dysfunction and Strengthens Bone in Laminin-α2–Deficient dy2J/dy2J Dystrophic Mice, received 2025-06-11 and accepted 2026-04-16, a review time of 309 days. With a single record, treat this as indicative only.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
